Astrazeneca Pharma India reports standalone net loss of Rs 13.41 crore in the December 2014 quarter
Sales decline 9.05% to Rs 108.12 crore
Net loss of Astrazeneca Pharma India reported to Rs 13.41 crore in the quarter ended December 2014 as against net profit of Rs 1.52 crore during the previous quarter ended December 2013. Sales declined 9.05% to Rs 108.12 crore in the quarter ended December 2014 as against Rs 118.88 crore during the previous quarter ended December 2013. ParticularsQuarter EndedDec. 2014Dec. 2013% Var.Sales108.12118.88 -9 OPM %-9.382.50 -PBDT-9.044.55 PL PBT-13.411.52 PL NP-13.411.52 PLPowered by Capital Market - Live News